Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.
about
Antiretroviral therapy for HIV-infected childrenEffects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South AfricaAdherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in EthiopiaBridging the gap between adult and paediatric outcomes in HIV-1 vertically infected children: a single-centre comparison with adult dataFive-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy.Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART eraTuberculosis and HIV co-infection in children.The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infectionHigh survival and treatment success sustained after two and three years of first-line ART for children in Cambodia.Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort studyMortality among HIV-1- and human herpesvirus type 8-affected mother-infant pairs in ZambiaPharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates.Adapting a Family-Based HIV Prevention Program for HIV-Infected Preadolescents and Their Families: Youth, Families and Health Care Providers Coming Together to Address Complex Needs.Guidance on vaccination of HIV-infected children in Europe.Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric populationPost-HAART outcomes in pediatric populations: comparison of resource-limited and developed countriesUnderdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study.Rate of candidiasis among HIV-infected children in Spain in the era of highly active antiretroviral therapy (1997-2008).PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. Pediatric European Network for Treatment of AIDS.Survival of HIV-infected children: a cohort study from the Asia-Pacific region.Risk of triple-class virological failure in children with HIV: a retrospective cohort studyCharacteristics of HIV infected adolescents in Latin America: results from the NISDI pediatric study.Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and countingSimian immunodeficiency virus infection in neonatal macaques.Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004)Under-two child mortality according to maternal HIV status in Rwanda: assessing outcomes within the National PMTCT Program.Adapting Evidence-Based Interventions to Meet the Needs of Adolescents Growing Up with HIV in South Africa: The VUKA Case Example.Transition of adolescents with HIV to adult care: characteristics and current practices of the adolescent trials network for HIV/AIDS interventions.Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.Antiretroviral therapy and mother-to-child transmission of HIV-1.Commentary: Questioning the HIV-AIDS Hypothesis: 30 Years of DissentShort-term mortality and implementation of antiretroviral treatment for critically ill HIV-infected children in a developing country.Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy.Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trialRecommendations in pediatric antiretroviral therapy.Antiretroviral therapy for children: challenges and opportunities.Anesthesia in HIV-infected children.
P2860
Q24247327-7D61B71D-16DF-424D-B716-77689CB1F6DBQ33249816-D708FB96-9B1A-4293-922C-8E1DCA32ADBBQ33279183-225BC7AD-60C3-4372-85F0-CE4A2D1C8052Q33390518-886B649D-694B-4079-9D2D-06BFBAE6CAFDQ33493535-1B5A0C7B-F02A-49A1-B6CD-3ED1517134E9Q33497040-617BF117-CBB4-48A1-84B6-4D17569EB6C0Q33553629-D146FD77-DBDA-4F52-BCC2-FEFF8D2E1D69Q33572442-395AFE08-31D8-4FB9-BEED-4DA663134131Q33592322-CDA17837-8E7B-47A1-826E-7DFE3FF3EA4FQ33673661-370E1779-949C-4882-981D-50BC835F986DQ33776928-456CC513-9781-48AA-BF5E-7D17A91797C4Q33885987-CFCD9EF0-33FC-4C95-B5DD-EDBCF9BBBB40Q33939293-929451F3-7538-4C0F-AA82-89034FD334C2Q33942351-B65E88F6-4565-44BF-AFAF-48F03F8052D9Q33983697-5BCFFD80-914C-4D61-A6B6-8C2A80EC861DQ34127790-604A4792-EDC2-45FF-A500-5408108721C0Q34251138-82045AC9-4517-4E0B-93AB-DDEF5A3AE08EQ34367468-7FBBBABA-592D-4CF9-8F69-0A391204D353Q34513045-67C25032-82F4-4565-B92F-D10F76A0C6F9Q34622948-A8E1A8D9-1689-4417-8653-72212D37A2F2Q34627658-036CE8C9-78E8-410C-9FFD-BE4E9B246C4FQ34760550-2B39EB7B-83DB-4149-84AC-05E42E337702Q34773604-A83F74BB-E97F-4D04-9A5D-24A13CD5555CQ34997180-DADE1B79-C735-4B00-B681-14B3599325C1Q35133104-1728C831-D32B-4813-A2FB-4B174C0359EBQ35160696-EEF02956-3B64-4AE6-BECD-26B99B2B8B50Q35182139-1DFA5BDB-4F47-46C1-A3A5-B744BC3A8CDEQ35452217-00971452-BE0A-459C-A198-CA474A4093D1Q35548335-A1E28BE5-0CD6-40AF-AE8D-DBD09B812E70Q35606329-97F8D191-E8EB-4F9E-BBD3-396032500F00Q35861579-5271745F-A47B-4B68-A69E-E489B20DE983Q35901126-5F2DF86B-4171-4052-8356-A306B9C4CE48Q35917533-9AA01EF7-4FC4-45D9-852F-6D4DE8956804Q35925705-D74F23A0-9531-4183-AB35-0F78581960DCQ36154492-C65D01F7-CE46-4FF0-BA7D-16D347584DC8Q36465148-2D8DEFAB-CD04-4679-8A27-3F0A3EEE618BQ36521955-9CADB86F-C5D8-49A7-835B-3A5570F27DA4Q36719674-2E94AC73-635A-4409-B3ED-798E7960EFE5Q36806770-F81D99C1-6B60-47F7-97C9-C709F36B094EQ36819830-CF812F08-AB8F-44F7-AC7C-546E0A1C3D43
P2860
Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Reduction in mortality with av ...... talian National AIDS Registry.
@ast
Reduction in mortality with av ...... talian National AIDS Registry.
@en
type
label
Reduction in mortality with av ...... talian National AIDS Registry.
@ast
Reduction in mortality with av ...... talian National AIDS Registry.
@en
prefLabel
Reduction in mortality with av ...... talian National AIDS Registry.
@ast
Reduction in mortality with av ...... talian National AIDS Registry.
@en
P2093
P921
P356
P1476
Reduction in mortality with av ...... talian National AIDS Registry.
@en
P2093
P304
P356
10.1001/JAMA.284.2.190
P407
P577
2000-07-01T00:00:00Z